Dasashil 50mg Tablet
Marketer
Shilpa Medicare Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasashil 50mg Tablet
Chronic myeloid leukemia (CML) is treated with Dasashil 50mg tablets, particularly in patients unresponsive to or intolerant of alternative leukemia therapies. Dasashil 50mg can be administered with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, abdominal pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) may occur; consult your doctor immediately if this happens. Regular blood pressure monitoring may be necessary. Avoid antacids within two hours of taking Dasashil. Reduced blood cell counts, increasing infection risk, necessitate regular blood tests. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Uses of Dasashil 50mg Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Dasashil 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 50mg Dasashil Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistency in timing is recommended.
Common Side effects of Dasashil 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasashil 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dasashil 50mg Tablets can be taken with or without food, however, consistent timing is recommended for optimal results.
How Dasashil 50mg Tablet works:
Dasashil 50mg tablets are an anticancer drug that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thereby suppressing or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dasashil 50mg Tablet lacks established safety data. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Dasashil 50mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. Exceptions may exist in life-threatening emergencies where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.
Breast feedingUNSAFE
Lactation and Dasashil 50mg tablets are incompatible. Evidence indicates a potential for infant harm from this medication.
DrivingUNSAFE
Dasashil 50mg Tablets can induce adverse reactions that may impair driving ability. Exercise caution while operating a vehicle if dizziness or blurred vision occurs after taking Dasashil 50mg Tablets.
KidneySAFE IF PRESCRIBED
Dasashil 50mg tablets appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
LiverSAFE IF PRESCRIBED
Dasashil 50mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dasashil 50mg Tablet :
Omit a missed Dasashil 50mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dasashil 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Kinase inhibitors targeting tyrosine |



